Effect of the bacillus of Calmette-Guerin, Propionibacterium aches and avridine as immunomodulators in antirabies vaccination of mice using the Fuenzalida-Palacios mouse brain vaccine

Vaccine

Volumn 17, Issue 19, 1999, Pages 2446-2452

  Megid, J ^a   Peracolli M T S ^a   Curi, P R ^a   Zanetti, C R ^b   Cabrera, W H ^c   Vassao, R ^c   Ito, F H ^d  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Instituto Pasteur de Sao Paulo   (Brazil)

^c INSTITUTO BUTANTAN   (Brazil)

^d Pasteur Institute ^*

Author keywords

Immunity; Immunomodulators; Mice; Rabies; Vaccination

Indexed keywords

AVRIDINE; BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; MACROPHAGE MIGRATION INHIBITION FACTOR; RABIES VACCINE;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; DELAYED HYPERSENSITIVITY; DIPLOIDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RABIES; RABIES VIRUS; VACCINATION;

EID: 0344731323     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00465-4     Document Type: Article

References (33)

1. Costy F. La vaccination antirabique de l'homme. Ann. Méd. Vét. 129:1985;353-359.
2. Bunn TO. Vaccines and vaccination of domestic animals. In: Campbell JB, Charlton KM , editors. Rabies. Boston: Kluwer Academic Publishers, 1988. p. 323-33.
3. Dreesen D.W. A global review of rabies vaccines for human use. Vaccine. 15 (Suppl.):1997;2-6.
4. Vodopija I, Clarke HF. Human vaccination against rabies. In: Baer GM, editor. The natural history of rabies. 2nd ed. Boca Raton, FL: CRC Press, 1991. p. 571-95.
5. Gluck R, Keiny MP. Vaccination against rabies. In: Crys SJ, Jr., editor. Vaccines and immunotherapy. Elmsford, NY: Pergamon Press, 1991. p. 246-55.
6. Tsiang H., Lagrange P.H. In vivo detection of specific cell-mediated immunity in street rabies virus infection in mice. J. Gen. Virol. 47:1980;183-191.
7. Celis E., Miller R.W., Wiktor T.J., Dietzschold B., Koprowski H. Isolation and characterization of human T-cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-γ J. Immunol. 136:1986;692-697.
8. Macfarlan R.I., Dietzschold B., Wiktor T.J., Kiel M., Houghten R., Lerner R.A., Sutcliffe J.G., Koprowski H. T-cell responses to cleaved rabies virus glycoprotein and to synthetic peptides. J. Immunol. 133:1984;2748-2752.
9. Wiktor T.J., Doherty P.C., Koprowski H. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc. Natl. Acad. Sci. USA. 74:1977;334-338.
10. Pille E.R., Vagabov M.A., Karakuyumchan M.K., Osyan K.S.M. Characteristics of cellular and humoral immune responses after immunization with different rabies vaccines. Acta Virol. 29:1985;137-142.
11. Barakat A.A., Saber M.S., Emad N., Abdel-Ghaffar S., El-Nimr M.M.H., Sobhy K., Fathia M., Mohsen A.Y.A., El-Nakashly S. Preliminary studies on the use of BCG as an immunopotentiating agent against Rift Valley Fever among sheep in Egypt. Bull. Office Int. Epizooties. 93:1981;1387-1393.
12. Spencer J.C., Ganguly R., Waldman R.H. Nonspecific protection of mice against influenza virus infection by local or systemic immunization with Bacille Calmette-Guérin. J. Infect. Dis. 136:1977;171-175.
13. Glasgow L.A., Fischbach J., Bryant S.M., Kern E.R. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum and Bacille Calmett-Guérin. J. Infect. Dis. 135:1977;763-770.
14. Al-Izzi S.A., Maxie M.G. Effect of Corynebacterium parvum on bone marrow macrophage colony production, peripheral blood leucocytes, and histologic changes of tissues in calves. Am. J. Vet. Res. 43:1982;2244-2247.
15. Cox W.I. Examining the immunologic and hematopoietic properties of an immunostimulant. Vet. Med. 83:1988;424-428.
16. Hoffman W.W., Korst J.J., Niblack J.F., Cronin T.H. N,N-dioctadecyl-N′,N′-bis(2-hydroxyethyl)propanediamine: antiviral activity and interferon stimulation in mice. Antimicrob. Agents Chemother. 3:1973;498-502.
17. Anderson A.O., Reynolds J.A. Adjuvant effects of the lipid amine CP-20,961. J. Reticuloendothelial Soc. 26:1979;667-680.
18. Nunberg J.H., Doyle M.V., York S.M., York C.J. Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine. Proc. Natl. Acad. Sci. USA. 86:1989;4240-4243.
19. Schijns V.E.C.J., Claassen I.J.T.M., Vermeulen A.A., Horzinek M.C., Osterhaus A.D.M.E. Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-α, interleukin-1α, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine. J. Gen. Virol. 75:1994;55-63.
20. Maharaj I., Froh K.J., Campbell J.B. Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin. Can. J. Microbiol. 32:1986;414-420.
21. Germano P.M.L., Silva E.V., Silva E.V., Cordeiro C.F., Preto A.A. Vacina anti-rábica PV/BHK com avridine como adjuvante. Avaliação da eficácia em camundongos. Arq. Biol. Tecnol. 33:1990;865-878.
22. Côrtes J.A., Rweyemamu M.M., Ito F.H., Umehara O., Medeiros Neto R.R., Lucca Neto D., Baltazar M.C., Vasconcellos S.A., Vasconcellos M.E.P. Immune response of cattle induced by inactivated rabies vaccine adjuvanted with either aluminium hydroxide alone or additionally with avridine. Rev. Sci. Office Int. Epizooties. 12:1993;941-955.
23. Niblack J.F., Otterness I.G., Hemsworth G.R., Wolff J.S., Hoffman W.W., Kraska A.R. CP-20,961: a structurally novel, synthetic adjuvant. J. Reticuloendothelial Soc. 26:1979;655-666.
24. Defaveri J., Rezkallah-Iwasso M.T., Franco M.F. Experimental pulmonary paracoccidioidomycosis in mice: morphology and correlations of lesions with humoral and cellular immune responses. Mycopathology. 77:1982;3-11.
25. Cherwinski H., Schumacher J., Browm K., Mosmann F. Two types of mouse helper cell clone. 3. Further differences in lymphokines synthesis between tH1 and tH2 clones revealed by DNA hybridization functionally monospecific bioassay and monoclonal antibody. J. Exp. Med. 166:1987;1229-1244.
26. Favoretto S.R., Carrieri M.L., Tino M.S., Zanetti C.R., Pereira O.A.C. Simplified fluorescence inhibition microtest for the titration of rabies neutralizing antibodies. Rev. Inst. Med. Trop. São Paulo. 35:1993;171-175.
27. Zar H. Biostatistical analysis. International Editions. 2nd ed. Englewood Cliffs: Prentice-Hall, 1984. 718 p.
28. Lagrange P.H., Tsiang H., Hurtrel B., Ravisse P. Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect. Immun. 21:1978;931-939.
29. Blancou J., Andral L., Lagrange P.H., Tsiang H. Kinetics of different specific immunological parameters after rabies vaccination in mice. Infect. Immun. 24:1979;600-605.
30. Tizard I. Round-table discussion. Eqstim® Immunostimulant. 37 Annual AAEP Meeting, 1992. J. Equine Vet. Sci. 12:1992;209-214.
31. Tizard I. Use of immunomodulators as an aid to clinical management of feline leukemia virus-infected cats. J. Am. Vet. Med. Assoc. 199:1991;1482-1485.
32. King A.A., Turner G.S. Rabies: a review. J. Comp. Path. 108:1993;1-39.
33. Wiktor T.J., Postic B., Monto H., Koprowski H. Role of interferon induction in the protective activity of rabies vaccine. J. Infect. Dis. 126:1972;408-417.